Skip to Content

BlackRock Future Health ETF BMED

Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis BMED

Will BMED outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin BlackRock Future Health ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

BlackRock Cash Funds Treasury SL Agency

4.81 190,000
Cash and Equivalents

Boston Scientific Corp

3.78 149,349
Healthcare

Cencora Inc

3.28 129,723
Healthcare

Intuitive Surgical Inc

2.81 111,019
Healthcare

Alnylam Pharmaceuticals Inc

2.73 107,958
Healthcare

West Pharmaceutical Services Inc

2.64 104,200
Healthcare

Amgen Inc

2.29 90,434
Healthcare

The Cooper Companies Inc

2.11 83,309
Healthcare

Blueprint Medicines Corp

1.92 75,707
Healthcare

Biomarin Pharmaceutical Inc

1.86 73,669
Healthcare